Stuttgart - Delayed Quote EUR
Corcept Therapeutics Inc (HTD.SG)
60.20
-1.56
(-2.53%)
As of 8:01:25 AM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
675,040
675,040
482,375
401,858
365,978
Cost of Revenue
10,882
10,882
6,481
5,385
5,281
Gross Profit
664,158
664,158
475,894
396,473
360,697
Operating Expense
527,207
527,207
368,612
283,839
236,220
Operating Income
136,951
136,951
107,282
112,634
124,477
Net Non Operating Interest Income Expense
24,542
24,542
17,275
3,557
529
Pretax Income
161,493
161,493
124,557
116,191
125,006
Tax Provision
20,284
20,284
18,417
14,773
12,494
Net Income Common Stockholders
139,733
139,733
105,496
101,288
112,512
Diluted NI Available to Com Stockholders
139,733
139,733
105,496
101,288
112,512
Basic EPS
1.36
1.35
1.02
0.95
0.97
Diluted EPS
1.26
1.23
0.94
0.87
0.89
Basic Average Shares
102,930.75
103,232
103,560
106,787
115,653
Diluted Average Shares
111,379.75
113,480
111,742
115,966
125,963
Total Operating Income as Reported
136,951
136,951
107,282
112,634
124,477
Total Expenses
538,089
538,089
375,093
289,224
241,501
Net Income from Continuing & Discontinued Operation
141,209
141,209
106,140
101,418
112,512
Normalized Income
141,209
141,209
106,140
101,418
112,512
Interest Income
24,542
24,542
17,275
3,557
529
Net Interest Income
24,542
24,542
17,275
3,557
529
EBIT
136,951
136,951
107,282
112,634
124,477
EBITDA
138,287
138,287
109,644
116,080
127,953
Reconciled Cost of Revenue
10,882
10,882
6,481
5,385
5,281
Reconciled Depreciation
1,336
1,336
2,362
3,446
3,476
Net Income from Continuing Operation Net Minority Interest
141,209
141,209
106,140
101,418
112,512
Normalized EBITDA
138,287
138,287
109,644
116,080
127,953
Tax Rate for Calcs
0
0
0
0
0
12/31/2021 - 8/28/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
AXD2.F Heron Therapeutics, Inc.
1.9010
+1.39%
RXK3.F SELLAS Life Sciences Group, Inc.
1.1500
-2.21%
REGN34.SA Regeneron Pharmaceuticals, Inc.
55.72
0.00%
REGN.VI Regeneron Pharmaceuticals, Inc.
515.20
-0.88%
BVNRY Bavarian Nordic A/S
7.72
0.00%
SNGX Soligenix, Inc.
2.0700
+0.49%
ICU SeaStar Medical Holding Corporation
1.2500
0.00%
XFOR X4 Pharmaceuticals, Inc.
0.2013
-0.84%
MREO Mereo BioPharma Group plc
2.5600
+2.40%
XERS Xeris Biopharma Holdings, Inc.
4.1300
+0.73%